pamidronate has been researched along with Signet Ring Cell Carcinoma in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nocturnal infusion of 5-fluorouracil (5-FU) combined with pamidronate was performed in a 62-year-old male gastric cancer patient with multiple bone metastasis." | 1.30 | [A case of gastric cancer with multiple bone metastasis treated by nocturnal 5-fluorouracil infusion combined with pamidronate]. ( Fukano, S; Furuya, Y; Kinugasa, T; Kohno, N; Maekawa, Y; Sekimoto, K; Toyokawa, A, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maekawa, Y | 1 |
| Furuya, Y | 1 |
| Toyokawa, A | 1 |
| Kinugasa, T | 1 |
| Fukano, S | 1 |
| Sekimoto, K | 1 |
| Kohno, N | 1 |
1 other study available for pamidronate and Signet Ring Cell Carcinoma
| Article | Year |
|---|---|
[A case of gastric cancer with multiple bone metastasis treated by nocturnal 5-fluorouracil infusion combined with pamidronate].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Signet Ring Cell; Diphosp | 1998 |